
When should I start migraine prevention therapy?
Reasons why you shoudl start migraine preventive therapy.

Reasons why you shoudl start migraine preventive therapy.

A 199-trial network analysis ranks migraine preventives by effectiveness and tolerability.

The AAN and AHS prevention guideline gives four drug lists instead of naming a single best drug.

One lot of propranolol (Inderal) extended-release 60 mg capsules was recalled on November 16, 2026 over possible metal pieces. Here is how to check your bottle…

In a 545-person head-to-head trial, fewer people stopped atogepant (Qulipta) because of side effects than topiramate (Topamax), and more had their migraine days cut in half.

In 5,438 people given CGRP antibody injections in Catalonia's public health system, about half of treatment courses cut headache days at least in half by 3…

A meta-analysis of 7 placebo-controlled trials linked probiotics to about 2 fewer migraine attacks a month, but the evidence was rated very low certainty and no…

A new network meta-analysis of 20 double-blind trials ranks vitamins and supplements for migraine prevention. Riboflavin 400 mg had the most reliable evidence, and magnesium showed…

In 96 adults starting a CGRP antibody or Botox, people whose migraine responded reported a bigger improvement in memory and concentration complaints than people whose migraine…

A 6,361-patient study found CGRP migraine preventives did not raise blood pressure faster than in similar patients not taking them. Atogepant (Qulipta) users also lost the…

Nearly half of US adults newly diagnosed with migraine filled an opioid prescription within 3 years, while fewer than 1 in 10 started prevention with a…

A meta-analysis of 19 studies and 3.6 million people linked migraine to modestly higher odds of glaucoma, a silent cause of vision loss. The link was…

A 2026 review gathered every published report of hair loss on CGRP antibodies and gepants. The signal is consistent across the class, the hair loss is…

A meta-analysis of 53 real-world studies found about three in four people were still on an anti-CGRP therapy at one year. Most who stopped did so…

In 479 real-world patients, Botox cut chronic migraine by about 6 headache days a month.

The AAN and AHS prevention guideline gives four drug lists instead of naming a single best drug.

Six trials and 3,453 people show how much atogepant cuts migraine days and which dose works best.

A review of 8 trials graded the evidence for ginger in migraine as low or very low certainty.

Sham-controlled trials show a modest benefit from acupuncture, on low-certainty evidence.

Real-world data on every-other-day rimegepant for prevention and why starting earlier helps.

In a one-year study of nearly 600 people on atogepant, average weight went down.

Real-world data show fremanezumab cut migraine days by nearly 6 a month.

A 199-trial network analysis ranks migraine preventives by effectiveness and tolerability.

Candesartan, a low-cost blood pressure pill, can prevent attacks. Dosing, safety and fit.

The AHS 2025 update on treating migraine in the emergency department, from 26 new trials.

In over 4,300 patients, CGRP antibodies stayed well tolerated past a year of treatment.

In one study, 70% on CGRP antibodies became super-responders, many only after 6 months.

Which supplements and herbs have real evidence for migraine, with dosing and safety.

How nerve blocks work for migraine, who is a candidate, and what to expect.

A guide to migraine preventive medications: classes, effectiveness, dosing and fit.

Practical ways to lower stroke risk if you have migraine, based on AHA/ASA guidance.

A trial tested fremanezumab (Ajovy) in people with both migraine and major depression.

Specialist tips on getting the most from acute and preventive migraine medications.

What expert guidelines recommend for acute and preventive migraine treatment.

Which patient traits predicted a good response to erenumab (Aimovig) in one study.

In real-world use, atogepant cut migraine days by more than half, even after other failures.

A three-year study suggests CGRP antibodies may change the course of migraine.

Which migraine preventives are more likely to be safe to combine.

How migraine medications are tested for safety and effectiveness before approval.

Early trials of Lu AG09222, an antibody against PACAP, show promise for prevention.

A 2024 study mapped how common 29 symptoms are across each migraine phase.

In one study, about 3% on CGRP antibodies had ECG changes or heart-related events.

How long to try a CGRP antibody before deciding whether it works for you.

The AHS now says CGRP-targeting treatments can be a first-line option for prevention.


What PACAP is, how it drives migraine, and where PACAP-targeting drugs stand.

The rationale for taking zinc to try to make Botox last longer.

Clinical Features VS Anti-CGRP Treatment Response

Memantine (Namenda): A Potential Off-Label Treatment for Migraine

Lamotrigine (Lamictal): A Potential Off-Label Treatment for Migraine (with aura)

Will I Respond Again To Anti-CGRP Monoclonal Antibody Therapy?

Reasons why you shoudl start migraine preventive therapy.

Duloxetine (Cymbalta): A Potential Off-Label Treatment for Migraine

Desvenlafaxine, a relative of venlafaxine, as an off-label migraine preventive.

Venlafaxine (Effexor): A Potential Off-Label Treatment for Migraine Prevention

Milnacipran, an SNRI approved for fibromyalgia, as an off-label migraine preventive.

50 Migraine Medications You May Have Not Heard of

Tension-Type Headache Preventive Treatment

How to choose a prescription preventive for episodic migraine with your neurologist.

Starting a preventive is a bit of an experiment, and it’s hard to judge from inside a bad month. The fairest way is to compare your…
Most migraine tracker journals are just symptom logs. Here is what actually matters in one, what the research says about diaries, and the tracker that includes…